Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65576 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Saxagliptin
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H25N3O2·H2OCouleur et forme :White Off-White Light Brown Crystalline PowderMasse moléculaire :333.20524Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H14FN·HClCouleur et forme :White PowderMasse moléculaire :191.11103Silodosin
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C25H32F3N3O4Couleur et forme :White Pale Yellow Crystalline PowderMasse moléculaire :495.23449Norepinephrine Related Compound D ((R)-4-(2-Amino-1-methoxyethyl)benzene-1,2-diol bitartrate hydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C9H13NO3·C4H6O6·H2OCouleur et forme :Light Brown Off-White SolidMasse moléculaire :183.08954Levetiracetam Related Compound B ((S)-2-aminobutanamide hydrochloride)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C4H10N2O·HClCouleur et forme :White Cream PowderMasse moléculaire :102.07931Metoprolol Related Compound B ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C12H17ClO3Couleur et forme :Pale Yellow Clear LiquidMasse moléculaire :244.08662Levetiracetam Related Compound A ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C8H15ClN2O2Couleur et forme :White Off-White CrystalsMasse moléculaire :206.08221Leflunomide Related Compound C (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :Yellow White PowderMasse moléculaire :270.06161Amiodarone Hydrochloride
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H29I2NO3·HClCouleur et forme :White PowderMasse moléculaire :681.78 g/molDeschloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-phenylpropan-1-one hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H19NO·HClCouleur et forme :White PowderMasse moléculaire :241.12334Levetiracetam
CAS :Lactams, nesoiFormule :C8H14N2O2Couleur et forme :White PowderMasse moléculaire :170.10553Ambrisentan Related Compound C (2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-hydroxy-3,3-diphenylpropanoic acid)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C21H20N2O4Couleur et forme :White Off-White SolidMasse moléculaire :364.14231Anastrozole Diacid (2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanoic acid))
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H21N3O4Couleur et forme :Off-White SolidMasse moléculaire :331.15321Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O4SCouleur et forme :Off-White PowderMasse moléculaire :361.10963Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C36H43NO6·H2OCouleur et forme :White SolidMasse moléculaire :603.3196(S)-Glycidyl Phthalimide ((S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione)
CAS :Imides and their derivatives (excluding sacharin), and salts thereofFormule :C11H9NO3Couleur et forme :White Off-White SolidMasse moléculaire :203.05824Iodoquinol
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5I2NOCouleur et forme :Light Brown Yellow PowderMasse moléculaire :396.84606Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C36H36N6O10Couleur et forme :Off-White SolidMasse moléculaire :712.24929Methoxy Carbamazepine (10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H14N2O2Couleur et forme :White Off-White SolidMasse moléculaire :266.10553Nilotinib Related Compound A (3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C11H10F3N3Couleur et forme :Beige PowderMasse moléculaire :241.08268Darunavir System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :PowderSaxagliptin Related Compound C ((1aS,4S,6aR,7aS)-4-[(1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl]hexahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione)
CAS :Lactams, nesoiFormule :C18H24N2O3Couleur et forme :White PowderMasse moléculaire :316.17869Norepinephrine Related Compound E (2-Chloro-1-(3,4-dihydroxyphenyl)ethan-1-one)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C8H7ClO3Couleur et forme :Dark Grey PowderMasse moléculaire :186.00837Atazanavir System Suitability Mixture (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer)
Compounds containing an unfused pyridine ring in the structure, nesoiCouleur et forme :White Light Yellow Crystalline PowderRegular Bleached Shellac
CAS :Natural gums, gum resins, resins and balsams nesoiCouleur et forme :PowderN-Nitroso Dabigatran Etexilate Solution (1 mL ) (ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N8O6Couleur et forme :Colorless LiquidMasse moléculaire :656.30708Atazanavir Ethyl Analog (methyl ((6S,11S,12S,15S)-12-benzyl-6-(tert-butyl)-11-hydroxy-16,16-dimethyl-4,7,14-trioxo-9-(4-(pyridin-2-yl)benzyl)-3-oxa-5,8,9,13-tetraazaheptadecan-15-yl)carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C39H54N6O7Couleur et forme :Off-White SolidMasse moléculaire :718.4054Sorafenib Formamide (4-(4-formamidophenoxy)-N-methylpicolinamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H13N3O3Couleur et forme :Off-White SolidMasse moléculaire :271.09569Aminophenylmorpholinone (4-(4-aminophenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O2Couleur et forme :White Off-White SolidMasse moléculaire :192.08988Amiodarone Related Compound H (2-chloro-N,N-diethylethanamine hydrochloride)
CAS :3-amino-3-methyl-1-butyne;2-chloro-n,n-dimethyl-ethylamine hydrochloride; 2-(diethylamino) isopropyl chloride hydrochlorideFormule :C6H14ClN·ClHCouleur et forme :Off-White PowderMasse moléculaire :171.05815Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H13NOCouleur et forme :White Off-White PowderMasse moléculaire :211.09971Topiramate Related Compound A (2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose)
CAS :Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C12H20O6Couleur et forme :White PowderMasse moléculaire :260.12599Fluphenazine Enanthate Dihydrochloride
CAS :Antidepressants, tranquilizers and other pschotherapeutic agentsFormule :C29H38F3N3O2S·2HClCouleur et forme :PowderMasse moléculaire :549.26368Norepinephrine Bitartrate
CAS :Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFormule :C8H11NO3·C4H6O6·H2OCouleur et forme :White Light Grey Crystalline PowderMasse moléculaire :337.1009Imidazole (1H-Imidazole)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C3H4N2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :68.03745Clozapine Benzoyl Methylpiperazine Analog (1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C18H21ClN4OCouleur et forme :Beige PowderMasse moléculaire :344.14039Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20FNO3·HClCouleur et forme :White PowderMasse moléculaire :365.1194Erlotinib Related Compound A (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C25H29N3O5·HClCouleur et forme :Off-White PowderMasse moléculaire :451.21072Nadolol
CAS :Aromatic drugs of amino-alcohols, other than those contFormule :C17H27NO4Couleur et forme :White PowderMasse moléculaire :309.4 g/molSildenafil Citrate
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C22H30N6O4S·C6H8O7Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :474.20492Aripiprazole Related Compound G (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C23H25Cl2N3O2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :445.13238N-Nitroso Bupropion (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C13H17ClN2O2Couleur et forme :SolidMasse moléculaire :268.09786Fluconazole Related Compound A (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C15H14FN9OCouleur et forme :White PowderMasse moléculaire :355.130532,4-Disulfamyl-5-Trifluoromethylaniline
CAS :Sulfonamides, nesoiFormule :C7H8F3N3O4S2Couleur et forme :PowderMasse moléculaire :318.99083Amiodarone Related Compound D ((2-Butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C19H16I2O3Couleur et forme :White Yellow PowderMasse moléculaire :545.91889Apixaban Related Compound F (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C22H20N4O6Couleur et forme :Light Brown PowderMasse moléculaire :436.13828o-Celecoxib (4-(5-(o-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White Off-White SolidMasse moléculaire :381.07588Omeprazole Related Compound F and G Mixture
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C16H13N3O2SCouleur et forme :Dark Brown PowderMasse moléculaire :311.07285Metoprolol Dimer (1,3-Bis[4-(2-methoxyethyl)phenoxy]propan-2-ol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormule :C21H28O5Couleur et forme :Colorless Light Yellow LiquidMasse moléculaire :360.19367Rivaroxaban Desthiophene Analog ((R)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H17N3O4Couleur et forme :White Off-White SolidMasse moléculaire :291.12191Desthiophenerivaroxaban Methylcarbamate Analog (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :349.12739Salmeterol Xinafoate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C25H37NO4·C11H8O3Couleur et forme :White PowderMasse moléculaire :415.27226Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderOndansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H20N2O·HClCouleur et forme :White SolidMasse moléculaire :256.15756Paroxetine Related Compound F ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22FNO3Couleur et forme :Light Tan PowderMasse moléculaire :343.15837Cyclam (1,4,8,11-Tetraazacyclotetradecane)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C10H24N4Couleur et forme :White Beige PowderMasse moléculaire :200.2001Nadolol Related Compound A ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol)
CAS :Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C13H18O5Couleur et forme :White SolidMasse moléculaire :254.11542Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS :Lactams, nesoiFormule :C26H25N5O5Couleur et forme :White Off-White PowderMasse moléculaire :487.18557Rivaroxaban N-methylphthalamido Analog ((S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H24N4O6Couleur et forme :White Off-White SolidMasse moléculaire :452.16958Oxcarbazepine Related Compound B (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H14N2O3Couleur et forme :White Yellow PowderMasse moléculaire :294.10044Sirolimus
CAS :Antibiotics nesoiFormule :C51H79NO13Couleur et forme :Off-White White PowderMasse moléculaire :913.55514Regorafenib
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H15ClF4N4O3·H2OCouleur et forme :White Brown PowderMasse moléculaire :500.08745Phenylethoxy Salmeterol (4-(1-hydroxy-2-((6-phenethoxyhexyl)amino)ethyl)-2-(hydroxymethyl)phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C23H33NO4Couleur et forme :White Off-White SolidMasse moléculaire :387.24096Bicalutamide Related Compound B ((RS)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C18H14F4N2O4SCouleur et forme :White Pale Pink PowderMasse moléculaire :430.37Clioquinol Related Compound B (5,7-Dichloroquinolin-8-ol)
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5Cl2NOCouleur et forme :White Off-White PowderMasse moléculaire :212.97482Leflunomide
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :White PowderMasse moléculaire :270.06161Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H13NOCouleur et forme :White Powder ClumpyMasse moléculaire :199.09971Fluticasone Propionate Related Compound J (6α, 9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormule :C21H26F2O5Couleur et forme :White Light Yellow Crystalline SolidMasse moléculaire :396.17483Omeprazole Related Compound C (5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylthio]-1H-benzimidazole)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O2SCouleur et forme :White Off-White PowderMasse moléculaire :329.1198Aripiprazole Related Compound F (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide)
CAS :Lactams not elsewhere specified or includedFormule :C23H27Cl2N3O3Couleur et forme :White Light Yellow PowderMasse moléculaire :464.39Rivaroxaban Related Compound D (1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)urea)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C29H32N6O9Couleur et forme :Off-White White SolidMasse moléculaire :608.22308Desmethoxyomeprazole
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H17N3O2SCouleur et forme :Light Brown Grey Yellow PowderMasse moléculaire :315.10415Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C12H18O4Couleur et forme :White Coarse Powder Semi-SolidMasse moléculaire :226.12051R,R,S-Ezetimibe ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C24H21F2NO3Couleur et forme :White Off-White SolidMasse moléculaire :409.148954-(Pyridin-2-yl)benzaldehyde (4-(Pyridin-2-yl)benzaldehyde)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H9NOCouleur et forme :Pale Yellow Off-White PowderMasse moléculaire :183.068415-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H5NO3Couleur et forme :White SolidMasse moléculaire :127.02694Hexyl Methanesulfonate
CAS :Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormule :C7H16O3SCouleur et forme :Clear Yellow LiquidMasse moléculaire :180.08202Dichlorothienoic Acid (4,5-dichlorothiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H2Cl2O2SCouleur et forme :Off-White SolidMasse moléculaire :195.91526Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O5SCouleur et forme :Light Brown Light Orange PowderMasse moléculaire :377.10454Fluphenazine Hydrochloride
CAS :Antidepressants, tranquilizers and other pschotherapeutic agentsFormule :C22H26F3N3OS·2ClHCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :509.128225-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C6H6O3Couleur et forme :Yellow SolidMasse moléculaire :126.03169Atazanavir Formyl Analog (methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-formamido-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C37H50N6O6Couleur et forme :Off-White SolidMasse moléculaire :674.37918Dibenzazepinodione (5H-dibenzo[b,f]azepine-10,11-dione)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H9NO2Couleur et forme :Dark Orange SolidMasse moléculaire :223.06333Rotigotine Related Compound C ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19NOS·HClCouleur et forme :Light Grey SolidMasse moléculaire :309.09541Alcohol
CAS :Ethyl alcohol, undenatured, of an alcoholic strength by volume of 80 percent vol. or higher, for nonbeverage purposes, excluding for fuel useFormule :C2H6OCouleur et forme :Clear Colorless LiquidMasse moléculaire :46.07Dabigatran Etexilate Related Compound B (Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate 4-toluenesulfonate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C27H29N7O3·C7H8O3SCouleur et forme :White Yellow PowderMasse moléculaire :671.2526Metoprolol Fumarate
CAS :Aromatic drugs of amino-alcohols, other than those contFormule :C34H54N2O10Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :650.8Plerixafor System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Off-White SolidDofetilide Related Compound A (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
CAS :Sulfonamides, nesoiFormule :C18H25N3O5S2Couleur et forme :White PowderMasse moléculaire :427.12356Fesoterodine Chloromandelate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C26H37NO3·C8H7ClO3Couleur et forme :White Fine PowderMasse moléculaire :411.27734Sunitinib Malate
CAS :Lactams not elsewhere specified or includedFormule :C22H27FN4O2·C4H6O5Couleur et forme :Yellow Orange PowderMasse moléculaire :532.23333Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFormule :C23H37N7O5SCouleur et forme :Off-White PowderMasse moléculaire :523.25769N-Nitroso Metoprolol Solution (1 mL ) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide)
CAS :Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormule :C15H24N2O4Couleur et forme :Colorless LiquidMasse moléculaire :296.17361Labetalol Related Compound A (2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzoic acid hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C19H23NO4·HClCouleur et forme :Off-White SolidMasse moléculaire :365.13939Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Paroxetine Methoxy (3R,4S)-Enantiomer Hydrochloride ((3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H23NO4·HClCouleur et forme :White Off-White SolidMasse moléculaire :341.16271Sildenafil Related Compound A (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H32N6O4SCouleur et forme :White PowderMasse moléculaire :488.22057Fluconazole
CAS :Anti-infective agents, nesoiFormule :C13H12F2N6OCouleur et forme :White Off-White PowderMasse moléculaire :306.10407Fluconazole Related Compound C (1,1'-(1,3-phenylene)di(1H-1,2,4-triazole))
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C10H8N6Couleur et forme :White PowderMasse moléculaire :212.08104
![Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478593.webp&w=3840&q=75)
![Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478561.webp&w=3840&q=75)
